We wish to report some corrections to our study \[[@B1]\], none of which alters the interpretation of the data or the conclusions drawn. After publication, we noticed that one of the micro-array hybridizations (on sample NB11) was performed on the same patient\'s material as another hybridization (sample NB4; see Table [1](#T1){ref-type="table"}; a corrected version of Table 5 \[[@B1]\]). As this error leads to an incorrect subclassification of the patients into the \'favourable\' and \'unfavourable\' neuroblastoma subgroups, we would like to exclude this data point from the differential expression analysis of favorable versus unfavorable neuroblastoma given under the heading \'Differential expression analysis of favorable and unfavorable neuroblastoma\' in the Results section of \[[@B1]\]. Careful reanalysis after exclusion of NB11 did not lead to important changes in the generated gene lists and conclusions; the changes are given in the corrected paragraph and Table [2](#T2){ref-type="table"} (a corrected version of Table 4 \[[@B1]\]), and the Additional data files 1 and 2 (corrected versions of Additional data files 2 and 3 \[[@B1]\]) available online with this article.

We also noticed that sample NB1 is stage 1 instead of stage 4S and that sample NB2 was not localized to the adrenals (see Table [1](#T1){ref-type="table"}).

Results
=======

Differential expression analysis of favorable and unfavorable neuroblastoma
---------------------------------------------------------------------------

So far, most published microarray studies on neuroblastomas mainly compared favorable with unfavorable neuroblastomas in order to identify prognostic markers or pathways that are involved in these clearly different neuroblastoma tumor types. In order to add value to such an analysis, we contrasted similar differentially expressed gene lists with the normal neuroblast expression profile (Additional data file 1). In a first step, we compared the differentially expressed genes between these two tumor types with published prognostic gene lists. We found that 23 of the 193 genes on our list were previously reported, including the well established markers *MYCN*, *NTRK1*, and *CD44*(see NBGS analysis in Additional data file 2). This overlap demonstrates the validity of the selected neuroblastoma panel and their expression profile. Subsequently, we looked for the corresponding gene expression levels of the differentially expressed genes in the normal counterpart cells, aiming to select neuroblastoma candidate genes. Of the 100 genes that are more highly expressed in favorable tumors (compared to unfavorable) 41 also have a significant differential expression (either higher or lower) compared to neuroblasts, whereas 43 of the 93 genes that are more highly expressed in unfavorable tumors exhibit differential expression compared to the neuroblasts (Table [2](#T2){ref-type="table"}).

From this analysis, a few putative positional tumor suppressor candidates emerge: *CDC42*on 1p36, *CACNA2D3*on 3p21 and *DLK1*on 14q. The latter two genes are of particular interest because they are highly expressed in neuroblasts and favorable neuroblastomas and their expression is significantly lower in unfavorable neuroblastomas. Among the genes that are more highly expressed in unfavorable neurob-lastomas than in favorable ones and neuroblasts, the proven oncogenic transcription factor *MYCN*emerges (and putative downstream genes *KIFAP3*, *OPHN1*, *RGS7*, *ASCL1*, *ODC1*, *TWIST1*and *TYMS*, according to NBGS), as well as several other genes that have been identified or studied in the context of neuroblastoma such as *ALK*and *PRAME*, and positional candidates on 17q including *BIRC5*and *RNU2*.

Additional data files
=====================

Additional data files [1](#S1){ref-type="supplementary-material"} and [2](#S2){ref-type="supplementary-material"} containing the corrected data available online with this article.

Supplementary Material
======================

###### Additional data file 1

Corrected version of Additional data file 2 \[1\].

###### 

Click here for file

###### Additional data file 2

Corrected version of Additional data file 3 \[1\].

###### 

Click here for file

Figures and Tables
==================

###### 

Clinical and genetic data of carefully selected neuroblastoma samples that were included in this study

  Sample number   Lab number   \% Tumor cells   Stage   MYCN amp   Ploidy   Adrenal localization   Age         Dead/alive   Overall survival (months)   Type
  --------------- ------------ ---------------- ------- ---------- -------- ---------------------- ----------- ------------ --------------------------- -------------
  NB1             98T33        95               1       No         Tri      Yes                    \< 1 year   Alive        76.9                        Favorable
  NB2             99T84        90               1       No         Tri      No                     \< 1 year   Alive        71.8                        Favorable
  NB3             96T82        90               1       No         Tri      Yes                    \< 1 year   Alive        115.5                       Favorable
  NB4             99T129       90               1       No         Tri      Yes                    \< 1 year   Alive        71.7                        Favorable
  NB5             01T28        90               4       Yes        Di       Yes                    \> 1 year   Dead         5.6                         Unfavorable
  NB6             03T304       100              3\*     No         Di       Abdominal              \> 1 year   Alive        12.0                        Unfavorable
  NB7             03T236       90               4       No         ND       Yes                    \> 5 year   Dead         19.4                        Unfavorable
  NB8             00T54        70               1       No         Tri      Yes                    \< 1 year   Alive        62.6                        Favorable
  NB9             00T35        \>95             4       Yes        Di       Yes                    \< 1 year   Dead         13.7                        Unfavorable
  NB10            99T125       80               3       No         Di       Yes                    \> 5 year   Alive        79.3                        Unfavorable
  NB11 = NB4      99T129       90               1       No         Tri      Yes                    \< 1 year   Alive        71.7                        Favorable
  NB12            02T192       100              4       Yes        Di       Abdominal              \> 5 year   Dead         16.2                        Unfavorable
  NB13            D031         \>95             4       No         Di       Abdominal              \> 1 year   Dead         64.8                        Unfavorable
  NB14            E002         \>80             4       No         ND       Abdominal              \> 1 year   Alive        65.7                        Unfavorable
  NB15            E037         \>80             4       No         ND       Abdominal              \> 1 year   Alive        45.3                        Unfavorable
  NB16            E044         \>80             4       No         ND       Yes                    \< 1 year   Alive        37.0                        Unfavorable
  NB17            E121         \>80             4       Yes        ND       Abdominal              \> 1 year   Dead         78.4                        Unfavorable
  NB18            04T121       60               3       Yes        Di       Yes                    \> 1 year   Dead         6                           Unfavorable

Samples were subdivided into favorable or unfavorable type based on *MYCN*amplification, ploidy and age at diagnosis. \*Neuroblastoma or nodular gan-glioneuroblastoma. ND, not determined or unknown.

###### 

Genes that are differentially expressed in favorable vs unfavorable neuroblastoma

  Favorable NB \> unfavorable NB                             NBGS                                                       Favorable NB \< unfavorable NB   NBGS                                                             
  ---------------------------------------------------------- ---------------------------------------------------------- -------------------------------- ---------------------------------------------------------- ----- ----
  neuroblast \< favorable NB                                 neuroblast \< favorable NB, neuroblast \< unfavorable NB                                                                                                     
                                                                                                                                                                                                                          
  *AKAP7*                                                    6q                                                         \-                               *FABP6*                                                    5q    \-
  *ARL4C*                                                    2q                                                         \-                               *IGLJ3*                                                    22q   1
  *ASPN*                                                     9q                                                         \-                               *NEFL*                                                     8p    \-
  *BCL2*                                                     18q                                                        1                                *NPY*                                                      7p    \-
                                                                                                                                                                                                                          
  *CALB1*                                                    8q                                                         \-                               neuroblast \< unfavorable NB                                     
                                                                                                                                                                                                                          
  *CAMK2B*                                                   22q                                                        2                                *ALK*                                                      2p    \-
  *CD24*                                                     6q                                                         \-                               *ASCL1*                                                    12q   1
  *CDC42*                                                    1p                                                         1                                *BCL11A*                                                   2p    \-
  *DDAH1*                                                    1p                                                         \-                               *BIRC5*                                                    17q   3
  *DNAPTP6*                                                  2q                                                         \-                               *C3*                                                       19p   \-
  *EPB41L3*                                                  18p                                                        1                                *CALCB*                                                    11p   \-
  *FAM70A*                                                   Xq                                                         \-                               *CCL18*                                                    17q   \-
  *KIFAP3*                                                   1q                                                         1                                *CCL21*                                                    9p    \-
  *OPHN1*                                                    Xq                                                         \-                               *CCNB1*                                                    5q    1
  *PPAN*                                                     19p                                                        \-                               *CD74*                                                     5q    \-
  *PRKCB1*                                                   16p                                                        1                                *CRH*                                                      8q    \-
  *REEP1*                                                    2p                                                         \-                               *CSPG3*                                                    19p   \-
  *RGS7*                                                     1q                                                         2                                *CXCR4*                                                    2q    2
  *RNF11*                                                    1p                                                         \-                               *DYNC1I1*                                                  7q    \-
  *SCD5*                                                     4q                                                         2                                *F12*                                                      5q    \-
  *SERINC1*                                                  6q                                                         1                                *GFRA2*                                                    8p    \-
  *ST6GALNAC5*                                               1p                                                         \-                               *IGHA1*                                                    14q   2
  *SV2C*                                                     5q                                                         \-                               *IGHG3*                                                    14q   \-
                                                                                                                                                                                                                          
  neuroblast \> favorable NB, neuroblast \> unfavorable NB   *IGHM*                                                     14q                              \-                                                               
                                                                                                                                                                                                                          
  *CACNA2D3*                                                 3p                                                         \-                               *IGKC*                                                     2p    1
  *DLK1*                                                     14q                                                        2                                *IGLC1*                                                    22q   \-
  *HBG1*                                                     11p                                                        \-                               *IGLC2*                                                    22q   \-
  *HBG2*                                                     11p                                                        \-                               *LMO3*                                                     12p   1
                                                                                                                                                                                                                          
  neuroblast \> unfavorable NB                               *MMP9*                                                     20q                              1                                                                
                                                                                                                                                                                                                          
  *ALDH3A2*                                                  17p                                                        1                                *MYCN*                                                     2p    9
  *DBH*                                                      9q                                                         1                                *NEFH*                                                     22q   \-
  *DLC1*                                                     8p                                                         \-                               *ODC1*                                                     2p    3
  *EYA1*                                                     8q                                                         \-                               *OGDHL*                                                    10q   \-
  *GCH1*                                                     14q                                                        1                                *P2RX5*                                                    17p   \-
  *HBA1*                                                     16p                                                        \-                               *PRAME*                                                    22q   1
  *HBA2*                                                     16p                                                        \-                               *RPS4Y1*                                                   Yp    1
  *NTRK1*                                                    1q                                                         4                                *SERPINF1*                                                 17p   \-
  *PTPRD*                                                    9p                                                         \-                               *SIX3*                                                     2p    \-
  *PTPRK*                                                    6q                                                         \-                               *SST*                                                      3q    1
  *SFRP1*                                                    8p                                                         1                                *TNFRSF10B*                                                8p    2
  *SLC18A1*                                                  8p                                                         \-                               *TWIST1*                                                   7p    1
  *TFAP2B*                                                   6p                                                         \-                               *XAGE1*                                                    Xp    \-
                                                                                                                                                                                                                          
  *TLN2*                                                     15q                                                        1                                neuroblast \> favorable NB                                       
                                                                                                                                                                                                                          
                                                                                                                                                         *RNU2*                                                     17q   \-
                                                                                                                                                                                                                          
                                                                                                                                                         neuroblast \> favorable NB, neuroblast \> unfavorable NB         
                                                                                                                                                                                                                          
                                                                                                                                                         *C11orf43*                                                 11p   \-

Genes that are differentially expressed compared with neuroblasts among the differentially expressed genes in favorable neuroblastoma (NB) vs unfavorable NB, with an indication of the number of neuroblastoma microarray studies in which these genes were found through NBGS analysis. NBGS, Neuroblastoma Gene Server.
